Alpha-synuclein kinase

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2713753

Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase.

Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau dun patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Alpha-synuclein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-synuclein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-synuclein kinase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1483114

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.